Above Food Ingredients Inc (ABVE) Fair Value & Analysis
Consumer Defensive · US · Market cap $5.8M
Fair value as of: Jun 26, 2026
Analysis
Above Food Ingredients Inc (ABVE) currently trades at $0.0998, while our model-based Fair Value estimate is $0.1148 — implying the stock looks roughly 15.0% undervalued today. We read business quality at 84/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Above Food Ingredients Inc., a regenerative ingredient company, produces vertically integrated supply chain products in Canada, the United States, Mexico, China, France, Turkey, and internationally. It operates through two segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods. The Disruptive Agriculture and Rudimentary Ingredients segment engages in the provisioning of discrete genetics, origination, purchasing, grading, processing, and sale of regeneratively grown grain; and origination, purchase, and sale of bespoke ingredients products. The Consumer Packaged Goods segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands; and focuses on manufacturing and distribution for private-labeled retail owned brands. Above Food Ingredients Inc. is based in Regina, Canada.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Above Food Ingredients Inc (ABVE) undervalued?
What is the fair value of ABVE?
What is the quality score of ABVE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.